| Active, not recruiting | 1 | 15 | US | Tenofovir Disoproxil Fumarate (TDF)-Emtricitabine (FTC), Placebo | Oak Crest Institute of Science, The Miriam Hospital, Johns Hopkins University, University of California, Los Angeles, University of California, San Diego, Vanderbilt University, The University of Texas Medical Branch, Galveston, National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) | HIV Prevention | 09/20 | 12/25 | | |
NCT04760691: Pre-Exposure Prophylaxis (PrEP)- Gender Affirming Hormone Therapy (GAHT) Interactions in TGW |
|
|
| Recruiting | 1 | 20 | US | Truvada alone, tenofovir disoproxil fumarate/emtricitabine (TDF/FTC), Truvada plus Leuprolide, Truvada plus Lupron, Truvada plus Estradiol 1 mg, Truvada plus low dose estrogen, Truvada plus Estradiol 6 mg, Truvada plus high dose estrogen, Estradiol 6 mg alone, Estradiol 6 mg | Johns Hopkins University, National Institute of Allergy and Infectious Diseases (NIAID) | Hiv, Prophylaxis, Transgender | 03/25 | 06/25 | | |
